MDAI
Spectral AI, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.52
+0.66%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$1.50
From 52W high−43.28%
Volume52107.00
Market cap$48.92M
P/E (TTM)—
P/S (TTM)3.2x
Div yield—
Key dataOct 19, 2026
Open
$1.50
From 52W high
−43.28%
Volume
52107.00
Market cap
$48.92M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−6.3x
P/E (TTM)
—
RSI (14)
37.0
MomentumView details →
1D Return
+0.66%
YTD Return
+6.69%
SummaryUpdated Jun 1, 2026
Spectral AI, Inc. (NASDAQ:MDAI) is a Dallas-based artificial intelligence company founded to revolutionize medical diagnostics in wound care. The company went public in April 2021 and has since focused on developing AI-powered diagnostic tools that help healthcare providers make faster and more accurate treatment decisions for patients with burns and diabetic foot ulcers. Spectral AI's flagship product, the DeepView system, represents a significant advancement in wound assessment technology, offering objective analysis capabilities that often surpass traditional clinical judgment.
Similar companies
Latest newsMore news →
Spectral AI submitted a New Technology Add-On Payment application to the Centers for Medicare & Medicaid Services (US) for its DeepView System through the alternative pathway.13d agoSpectral AI completed the first Site Initiation Visit for a clinical study supporting label expansion of its FDA-cleared DeepView System for Burn Indication to include burns of the head, hands, and feet, conducted at Pinderfields Hospital in Wakefield, UK.18d agoSpectral AI announced a scheduled presentation at the ACS Clinical Congress 2026 in Washington, DC, on the use of artificial intelligence and multi-spectral imaging in assessing burn wounds.25d ago